INTERACTION OF D, L-TETRAPLATIN AND D-TETRAPLATIN WITH HYPERTHERMIA INVITRO AND INVIVO

被引:6
作者
EPELBAUM, R [1 ]
TEICHER, BA [1 ]
HOLDEN, SA [1 ]
ARA, G [1 ]
VARSHNEY, A [1 ]
HERMAN, TS [1 ]
机构
[1] JOINT CTR RADIAT THERAPY,BOSTON,MA 02115
关键词
D O I
10.1016/0959-8049(92)90117-K
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cytotoxicities of D,L-tetraplatin and D-tetraplatin were evaluated at 37-degrees-C, 42-degrees-C and 43-degrees-C at normal pH, at pH 6.45 and under normally oxygenated and hypoxic conditions in EMT-6 cells in vitro. The D-isomer was also tested in FSaIIC cells in vitro. Under these various conditions the pure D-isomer was very similar in cytotoxicity with the racemic mixture. Like cisplatin, both D,L- and D-tetraplatin were selectively cytotoxic toward normally oxygenated cells under acidic pH (6.45) conditions at 37-degrees-C. In both cell lines the cytotoxicity of D,L- and D-tetraplatin was markedly increased at hyperthermic temperatures. Under the same conditions platinum levels in EMT-6 cells exposed to D,L- or D-tetraplatin were higher than in cells exposed to cisplatin, and unlike cisplatin there was an increase in intracellular platinum levels when the cells were exposed to D,L- or D-tetraplatin at 42-degrees-C compared with 37-degrees-C. The tumour growth delay of the FSaIIC fibrosarcoma was the same for D,L- and D-tetraplatin. A dose of 10 mg/kg intraperitoneally of tetraplatin produced a tumour growth delay of about 4.3 days which was increased to about 6 days with the addition of local hyperthermia (43-degrees-C, 30 min) to the drug treatment. The tumour cell survival assay also showed no difference between D,L- and D-tetraplatin and a log-linear increase in tumour cell killing with increasing drug dose which was increased 1.5-3-fold with local hyperthermia. D,L- and D-tetraplatin were relatively much more cytotoxic toward bone marrow colony forming units of granulocyte-macrophage progenitors (CFU-GM) than was cisplatin and this cytotoxicity was increased about 5-10-fold under hyperthermic conditions. There was an increase in DNA crosslink formation in tumours when hyperthermia accompanied tetraplatin treatment. Overall, D,L- and D-tetraplatin produced very similar responses under hyperthermic conditions in both tumour and normal tissues, and may be a useful agent in combination with local hyperthermia.
引用
收藏
页码:794 / 800
页数:7
相关论文
共 53 条
[1]  
Adams G E, 1982, Natl Cancer Inst Monogr, V61, P27
[2]  
CHANEY S G, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P470
[3]  
CHANEY SG, 1990, CANCER RES, V50, P4539
[4]  
COHEN JD, 1987, CANCER RES, V47, P4335
[5]   TUMORICIDAL INTERACTIONS OF HYPERTHERMIA WITH CARBOPLATIN, CISPLATIN AND ETOPOSIDE [J].
COHEN, JD ;
ROBINS, HI ;
SCHMITT, CL .
CANCER LETTERS, 1989, 44 (03) :205-210
[6]  
COHEN JD, 1990, INT J HYPERTHERM, V6, P1031
[7]  
DAHL O, 1986, HYPERTHERMIA, P121
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF PLATINUM(II) IN PLASMA ULTRAFILTRATE AND URINE - COMPARISON WITH A FLAMELESS ATOMIC-ABSORPTION SPECTROMETRIC METHOD [J].
DRUMMER, OH ;
PROUDFOOT, A ;
HOWES, L ;
LOUIS, WJ .
CLINICA CHIMICA ACTA, 1984, 136 (01) :65-74
[10]  
ENGLEHARDT R, 1987, RECENT RES CANCER RE, V104, P133